Correlation of initial wellness with long-term morbidity in recurrent major affective disorder patients as a test of survival analysis

Journal of Clinical Psychopharmacology

Volumn 30, Issue 1, 2010, Pages 72-75

  Baldessarini, Ross J ^a,b   Tondo, Leonardo ^a,b   Lepri, Beatrice ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Assumptions; Bipolar disorder; Lithium; Major depression; Survival analysis; Treatment

Indexed keywords

LITHIUM;

ADULT; ARTICLE; BIPOLAR DISORDER; FEMALE; HUMAN; MAJOR AFFECTIVE DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; MORBIDITY; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SURVIVAL; WELLBEING;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; PROGNOSIS; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 74549164173     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181c9fdd3     Document Type: Article

References (15)

1. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000;57:481-489.
2. Gyulai L, Bowden CL, McElroy SL, et al. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology. 2003;28:1374-1382.
3. Baldessarini RJ, Tarazi FI. Drug therapy of depression and anxiety disorders, and pharmacotherapy of psychosis and mania. Chapters 17 and 18. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill Press; 2005:429-500.
4. Calabrese JR, Goldberg JF, Ketter TA, et al. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiatry. 2006;59:1061-1064.
5. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507.
6. Goodwin FK, Jamison KR. Manic-Depressive Illness. 2nd ed. New York, NY: Oxford Press; 2006.
7. Tohen M, Calabrese JR, Sachs GS, et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry. 2006;163:247-256.
8. Viguera AC, Whitfield T, Baldessarini RJ, et al. Recurrences of bipolar disorder in pregnancy: prospective study of mood-stabilizer discontinuation. Am J Psychiatry. 2007;164:1817-1824.
9. Biederman J, Petty CR, Dolan C, et al. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med. 2008;38:1027-1036.
10. Vieta E, Angst J, Reed C, et al. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). J Affect Disord. 2009;118:118-123.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
12. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry. 2001;178(suppl 41):184-190.
13. Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord. 2003;5:169-179.
14. Tondo L, Lepri B, Baldessarini RJ. Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr Scand. 2007;116:419-428.
15. Perlis RH, Sachs GS, Lafer B, et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry. 2002;159:1155-1159.